ATE.v/ATBPF +.025 to C$.415 Antibe continues to trade significant volume. Maybe Antibe has attracted a bigger player that likes their drug candidate, ATB-346.
Phase II study on best dosage should be done this fall and results early winter. Company is saying this study was needed to provide good info to potential big pharma partners who will fund phase III studies.
Please post stock symbols first in all your posts. If it's a foreign stock, please list the US pk equivalent symbol.
If the Commodities Boom is Over, I am just a Gold Bug headed for the Windshield of LIFE